Experimental and Clinical Evaluation of Nootropic Activity of Bacopa monniera Linn. (Brahmi)

Autor: B N Dhawan
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Zdroj: Annals of the National Academy of Medical Sciences (India), Vol 50, Iss 1 & 2, Pp 20-33 (2015)
Druh dokumentu: article
ISSN: 0379-038X
2454-5635
Popis: Bacopa monniera Linn. (Brahmi) is an annual creeper belonging to familyScrophulariaceae and growing all over the Indian sub-continent in marshy areas. It is a major Medhya Rasayana used in Ayurveda for treatment of memory disorders. Large number of saponins and glycosides has been isolated from the plant. Most of the experimental and clinical studies have been done with crude extracts or standardized preparation of the two active saponins Bacosides A and B.Extracts or saponin mixture facilitate learning, improve consolidation of learned behavior and delay extinction in several models of learnt behavior in normal rats and mice as well as in chemically induced or transgenic models of Alzheimer's disease. They also prevent or reverse amnesia produced by drugs, stress or ischemic hypoxia. Other CNS effects include anti-anxiety, anti-convulsant and analgesic activity. Several mechanisms have been proposed to explain the mechanism of these CNS effects.Extracts as well as the bacoside preparation have been found safe and well tolerated in healthy volunteers in single dose or chronic administration for several weeks in a number of double blind placebo controlled studies in India and abroad. Chronic administration significantly improved information processing, learning and memory consolidation. It was found more effective than caffeine in a comparative study.Double blind placebo controlled studies with bacoside preparation have demonstrated beneficial effects and safety in elderly patients with Age Related Memory Impairment and in children with Attention Deficit Memory Disorder. It has also been found useful in anxiety neurosis, epilepsy and sleep disturbances in post menopausal women.The standardized preparation is marketed as a prescription drug after having obtained the necessary regulatory approval in India, Australia, New Zealand and South Africa and as an OTC product in several other south east Asian and African countries.Bacopa monniera Linn. (Brahmi) is an annual creeper belonging to familyScrophulariaceae and growing all over the Indian sub-continent in marshy areas. It is amajor Medhya Rasayana used in Ayurveda for treatment of memory disorders. Largenumber of saponins and glycosides has been isolated from the plant. Most of theexperimental and clinical studies have been done with crude extracts or standardizedpreparation of the two active saponins Bacosides A and B.Extracts or saponin mixture facilitate learning, improve consolidation of learnedbehavior and delay extinction in several models of learnt behavior in normal rats andmice as well as in chemically induced or transgenic models of Alzheimer's disease.They also prevent or reverse amnesia produced by drugs, stress or ischemic hypoxia.Other CNS effects include anti-anxiety, anti-convulsant and analgesic activity. Severalmechanisms have been proposed to explain the mechanism of these CNS effects.Extracts as well as the bacoside preparation have been found safe and well tolerated inhealthy volunteers in single dose or chronic administration for several weeks in anumber of double blind placebo controlled studies in India and abroad. Chronicadministration significantly improved information processing, learning and memoryconsolidation. It was found more effective than caffeine in a comparative study.Double blind placebo controlled studies with bacoside preparation have demonstratedbeneficial effects and safety in elderly patients with Age Related Memory Impairmentand in children with Attention Deficit Memory Disorder. It has also been found usefulin anxiety neurosis, epilepsy and sleep disturbances in post menopausal women.The standardized preparation is marketed as a prescription drug after having obtainedthe necessary regulatory approval in India, Australia, New Zealand and South Africaand as an OTC product in several other south east Asian and African countries.Bacopa monniera Linn. (Brahmi) is an annual creeper belonging to familyScrophulariaceae and growing all over the Indian sub-continent in marshy areas. It is a major Medhya Rasayana used in Ayurveda for treatment of memory disorders. Large number of saponins and glycosides has been isolated from the plant. Most of the experimental and clinical studies have been done with crude extracts or standardized preparation of the two active saponins Bacosides A and B.Extracts or saponin mixture facilitate learning, improve consolidation of learned behavior and delay extinction in several models of learnt behavior in normal rats and mice as well as in chemically induced or transgenic models of Alzheimer's disease. They also prevent or reverse amnesia produced by drugs, stress or ischemic hypoxia. Other CNS effects include anti-anxiety, anti-convulsant and analgesic activity. Several mechanisms have been proposed to explain the mechanism of these CNS effects.Extracts as well as the bacoside preparation have been found safe and well tolerated in healthy volunteers in single dose or chronic administration for several weeks in a number of double blind placebo controlled studies in India and abroad. Chronic administration significantly improved information processing, learning and memory consolidation. It was found more effective than caffeine in a comparative study.Double blind placebo controlled studies with bacoside preparation have demonstrated beneficial effects and safety in elderly patients with Age Related Memory Impairment and in children with Attention Deficit Memory Disorder. It has also been found useful in anxiety neurosis, epilepsy and sleep disturbances in post menopausal women.The standardized preparation is marketed as a prescription drug after having obtained the necessary regulatory approval in India, Australia, New Zealand and South Africa and as an OTC product in several other south east Asian and African countries.Bacopa monniera Linn. (Brahmi) is an annual creeper belonging to familyScrophulariaceae and growing all over the Indian sub-continent in marshy areas. It is amajor Medhya Rasayana used in Ayurveda for treatment of memory disorders. Largenumber of saponins and glycosides has been isolated from the plant. Most of theexperimental and clinical studies have been done with crude extracts or standardizedpreparation of the two active saponins Bacosides A and B.Extracts or saponin mixture facilitate learning, improve consolidation of learnedbehavior and delay extinction in several models of learnt behavior in normal rats andmice as well as in chemically induced or transgenic models of Alzheimer's disease.They also prevent or reverse amnesia produced by drugs, stress or ischemic hypoxia.Other CNS effects include anti-anxiety, anti-convulsant and analgesic activity. Severalmechanisms have been proposed to explain the mechanism of these CNS effects.Extracts as well as the bacoside preparation have been found safe and well tolerated inhealthy volunteers in single dose or chronic administration for several weeks in anumber of double blind placebo controlled studies in India and abroad. Chronicadministration significantly improved information processing, learning and memoryconsolidation. It was found more effective than caffeine in a comparative study.Double blind placebo controlled studies with bacoside preparation have demonstratedbeneficial effects and safety in elderly patients with Age Related Memory Impairmentand in children with Attention Deficit Memory Disorder. It has also been found usefulin anxiety neurosis, epilepsy and sleep disturbances in post menopausal women.The standardized preparation is marketed as a prescription drug after having obtainedthe necessary regulatory approval in India, Australia, New Zealand and South Africaand as an OTC product in several other south east Asian and African countries.
Databáze: Directory of Open Access Journals
Externí odkaz: